Nikhil Mehta
No más puestos en curso
Historial de carrera de Nikhil Mehta
Antiguos cargos conocidos de Nikhil Mehta.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Consejero General | 20/11/2017 | 08/10/2019 |
| BAXALTA INC | Consejero General | 01/04/2015 | 01/06/2016 |
| MERCK & CO., INC. | Consejero General | 01/01/2010 | 01/01/2015 |
Tang Capital Management LLC
 Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | Consejero General | - | - |
Formación de Nikhil Mehta.
| Rutgers State University of New Jersey | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Francia | 2 |
Operativa
| General Counsel | 4 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | Finance |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Nikhil Mehta
- Experiencia
